Medical researchers are optimistic that 2026 will be the year gene editing becomes a standard medical procedure. From treating rare blood disorders to preventing hereditary conditions, the potential is vast.
Genetic Engineering: The End of Hereditary Diseases?
CRISPR-Cas9 treatments enter final human trials for multiple genetic conditions.
No comments yet. Be the first to join the conversation!